Total amount raised
$57.2 Millions
Latest funding date
05/01/2022
Location
Osmind has successfully raised funds through multiple rounds, with the latest being a Series B round closed on May 10, 2022. The company specializes in technology platforms for breakthrough mental health treatment and research.
With the backing of 21 investors, Osmind continues to advance its mission in the mental health sector. Keep reading to explore the intricacies of Osmind's fundraising journey and the investors supporting this innovative platform.
What Is Osmind?
Osmind, founded in 2020, is a San Francisco-based company specializing in health care, medical, and mental health industries. The company was established by Jimmy Qian and Lucia Huang.
With a team of 51-100 employees, Osmind offers a technology platform focused on breakthrough mental health treatment and research. Their services include a comprehensive electronic health record system, patient engagement tools, and a research platform, supporting a network of over 800 independent psychiatry practices.
How Much Funding Has Osmind Raised?
- Pre-Seed Round
- Amount Raised: $175K
- Date: August 2020
- Lead Investors: Y Combinator
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To kickstart the development of their technology platform for mental health treatment and research.
- Seed Round
- Amount Raised: $2M
- Date: October 2020
- Lead Investors: General Catalyst
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To expand their electronic health record software and analytics platform.
- Series A
- Amount Raised: $15M
- Date: July 2021
- Lead Investors: Future Ventures
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To scale their operations and enhance their product offerings.
- Series B
- Amount Raised: $40M
- Date: May 2022
- Lead Investors: DFJ Growth
- Valuation at Round: Not publicly disclosed
- Motivation Behind the Round: To advance their technology platform and support further research and development.
Total Amount Raised: $57.175M. Current Valuation: Not publicly disclosed.
Key Investors
- DFJ Growth
- Details: DFJ Growth is a venture capital firm that invests in high-growth technology companies. They focus on companies that have the potential to become market leaders.
- Investment Focus Areas: Technology, healthcare, energy.
- Notable Investments: SpaceX, Tesla, Twitter.
- Future Ventures
- Details: Future Ventures is a venture capital firm that invests in frontier technologies. They aim to support companies that are pushing the boundaries of innovation.
- Investment Focus Areas: Biotechnology, artificial intelligence, space exploration.
- Notable Investments: SpaceX, Neuralink, Planet Labs.
- General Catalyst
- Details: General Catalyst is a venture capital firm that provides early-stage and growth-stage funding. They partner with entrepreneurs to build companies that have a lasting impact.
- Investment Focus Areas: Healthcare, technology, consumer products.
- Notable Investments: Airbnb, Stripe, Snap.
- Y Combinator
- Details: Y Combinator is a startup accelerator that provides seed funding and mentorship. They have supported thousands of startups since their inception.
- Investment Focus Areas: Technology, healthcare, consumer products.
- Notable Investments: Dropbox, Airbnb, Stripe.
- Pear VC
- Details: Pear VC is a venture capital firm that invests in early-stage startups. They focus on helping founders build category-defining companies.
- Investment Focus Areas: Technology, healthcare, consumer products.
- Notable Investments: DoorDash, Guardant Health, Gusto.
What's Next for Osmind?
Osmind stands at the cusp of significant growth, driven by the expansion of their electronic health record software and analytics platform. With a focus on enhancing patient engagement and remote monitoring, the company is poised to address the needs of treatment-resistant mental health populations. This opportunity is vast, given their current reach of over 20,000 patients across 125 practices in more than 30 states.
Future fundraising opportunities are likely as Osmind continues to scale its operations and enhance its platform. The increasing focus on mental health and innovative treatments like psychedelic medicine and neuromodulation presents a fertile ground for attracting investment from venture capital firms. However, challenges such as ensuring data privacy, navigating regulatory requirements, and competing with other mental health technology providers will need to be managed carefully.
Use Clay to Get Funding Data
Sales professionals, leverage Clay’s platform to access comprehensive fundraising data on companies like Osmind and gather other critical business insights. Sign up for free to start transforming your sales strategy today.
